XML 74 R63.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidating Financial Statements of Aramark and Subsidiaries - Statements of Income And Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Mar. 29, 2019
Mar. 30, 2018
Mar. 29, 2019
Mar. 30, 2018
Condensed Financial Statements, Captions [Line Items]        
Revenue $ 3,999,987 $ 3,939,311 $ 8,265,336 $ 7,904,429
Cost of services provided 3,639,959 3,563,009 7,434,404 7,085,239
Costs and Expenses:        
Depreciation and amortization 147,908 152,864 298,629 286,713
Selling and general corporate expenses 88,285 88,444 192,415 180,612
Gain on sale of Healthcare Technologies 1,000 0 (156,309) 0
Interest and other financing costs, net 84,178 92,653 167,155 166,786
Expense allocations 0 0 0 0
Total Costs and Expenses 3,961,330 3,896,970 7,936,294 7,719,350
Income (Loss) before Income Tax 38,657 42,341 329,042 185,079
Provision (Benefit) for Income Taxes 9,347 14,625 49,054 (135,077)
Equity in Net Income of Subsidiaries 0 0 0 0
Net income 29,310 27,716 279,988 320,156
Less: Net income (loss) attributable to noncontrolling interest (43) 147 (49) 303
Net income attributable to Aramark stockholders 29,353 27,569 280,037 319,853
Other comprehensive income, net of tax (8,655) 49,460 (50,428) 61,065
Comprehensive income attributable to Aramark stockholders 20,698 77,029 229,609 380,918
Eliminations        
Condensed Financial Statements, Captions [Line Items]        
Revenue 0 0 0 0
Cost of services provided 0 0 0 0
Costs and Expenses:        
Depreciation and amortization 0 0 0 0
Selling and general corporate expenses 0 0 0 0
Gain on sale of Healthcare Technologies 0   0  
Interest and other financing costs, net 0 0 0 0
Expense allocations 0 0 0 0
Total Costs and Expenses 0 0 0 0
Income (Loss) before Income Tax 0 0 0 0
Provision (Benefit) for Income Taxes 0 0 0 0
Equity in Net Income of Subsidiaries (29,353) (27,569) (280,037) (319,853)
Net income (29,353) (27,569) (280,037) (319,853)
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders (29,353) (27,569) (280,037) (319,853)
Other comprehensive income, net of tax 22,964 (67,490) 95,266 (91,881)
Comprehensive income attributable to Aramark stockholders (6,389) (95,059) (184,771) (411,734)
Aramark (Parent) | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 0 0 0 0
Cost of services provided 0 0 0 0
Costs and Expenses:        
Depreciation and amortization 0 0 0 0
Selling and general corporate expenses 0 0 0 0
Gain on sale of Healthcare Technologies 0   0  
Interest and other financing costs, net 0 0 0 0
Expense allocations 0 0 0 0
Total Costs and Expenses 0 0 0 0
Income (Loss) before Income Tax 0 0 0 0
Provision (Benefit) for Income Taxes 0 0 0 0
Equity in Net Income of Subsidiaries 29,353 27,569 280,037 319,853
Net income 29,353 27,569 280,037 319,853
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders 29,353 27,569 280,037 319,853
Other comprehensive income, net of tax (8,655) 49,460 (50,428) 61,065
Comprehensive income attributable to Aramark stockholders 20,698 77,029 229,609 380,918
Issuers | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 260,057 252,354 528,579 510,625
Cost of services provided 234,485 220,756 481,094 445,972
Costs and Expenses:        
Depreciation and amortization 3,817 5,383 8,289 9,874
Selling and general corporate expenses 35,870 48,458 91,612 102,124
Gain on sale of Healthcare Technologies 0   0  
Interest and other financing costs, net 78,353 88,220 156,912 159,395
Expense allocations 85,651 (80,805) (144,938) (146,008)
Total Costs and Expenses 438,176 282,012 592,969 571,357
Income (Loss) before Income Tax (178,119) (29,658) (64,390) (60,732)
Provision (Benefit) for Income Taxes (35,757) (7,195) (27,017) (27,904)
Equity in Net Income of Subsidiaries 0 0 0 0
Net income (142,362) (22,463) (37,373) (32,828)
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders (142,362) (22,463) (37,373) (32,828)
Other comprehensive income, net of tax (17,074) 17,434 (44,425) 22,823
Comprehensive income attributable to Aramark stockholders (159,436) (5,029) (81,798) (10,005)
Guarantors | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 2,629,407 2,605,150 5,478,334 5,248,416
Cost of services provided 2,375,337 2,306,776 4,839,939 4,626,967
Costs and Expenses:        
Depreciation and amortization 118,261 127,270 239,243 233,165
Selling and general corporate expenses 45,374 34,506 86,926 68,204
Gain on sale of Healthcare Technologies 1,000   (156,309)  
Interest and other financing costs, net 1,036 470 2,007 537
Expense allocations (89,505) 76,189 136,296 137,299
Total Costs and Expenses 2,451,503 2,545,211 5,148,102 5,066,172
Income (Loss) before Income Tax 177,904 59,939 330,232 182,244
Provision (Benefit) for Income Taxes 35,298 12,056 60,298 (130,391)
Equity in Net Income of Subsidiaries 0 0 0 0
Net income 142,606 47,883 269,934 312,635
Less: Net income (loss) attributable to noncontrolling interest (43) 147 (49) 303
Net income attributable to Aramark stockholders 142,649 47,736 269,983 312,332
Other comprehensive income, net of tax 0 2,181 0 2,181
Comprehensive income attributable to Aramark stockholders 142,649 49,917 269,983 314,513
Non Guarantors | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 1,110,523 1,081,807 2,258,423 2,145,388
Cost of services provided 1,030,137 1,035,477 2,113,371 2,012,300
Costs and Expenses:        
Depreciation and amortization 25,830 20,211 51,097 43,674
Selling and general corporate expenses 7,041 5,480 13,877 10,284
Gain on sale of Healthcare Technologies 0   0  
Interest and other financing costs, net 4,789 3,963 8,236 6,854
Expense allocations 3,854 4,616 8,642 8,709
Total Costs and Expenses 1,071,651 1,069,747 2,195,223 2,081,821
Income (Loss) before Income Tax 38,872 12,060 63,200 63,567
Provision (Benefit) for Income Taxes 9,806 9,764 15,773 23,218
Equity in Net Income of Subsidiaries 0 0 0 0
Net income 29,066 2,296 47,427 40,349
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders 29,066 2,296 47,427 40,349
Other comprehensive income, net of tax (5,890) 47,875 (50,841) 66,877
Comprehensive income attributable to Aramark stockholders $ 23,176 $ 50,171 $ (3,414) $ 107,226